Nicodicodeine

This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (January 2007)

Nicodicodeine

Systematic (IUPAC) name
(5α,6α)-3-methoxy- 17-methyl- 4,5-epoxymorphinan- 6-yl nicotinate
Clinical data
Pregnancy cat.	?
Legal status	Schedule I (US)
Routes	Oral, intravenous
Identifiers
CAS number	808-24-2
ATC code	None
PubChem	CID 5464304
ChemSpider	4576612 Y
Synonyms	6-Nicotinoyldihydrocodeine
Chemical data
Formula	C24H26N2O4
Mol. mass	406.474 g/mol
SMILES	eMolecules & PubChem
InChI InChI=1S/C24H26N2O4/c1-26-11-9-24-16-6-8-19(29-23(27)15-4-3-10-25-13-15)22(24)30-21-18(28-2)7-5-14(20(21)24)12-17(16)26/h3-5,7,10,13,16-17,19,22H,6,8-9,11-12H2,1-2H3/t16-,17+,19-,22-,24-/m0/s1 Y Key:GTGRMWCOZHEYRL-MJFIPZRTSA-N Y
Y(what is this?)  (verify)

Nicodicodeine is an opiate derivative developed as a cough suppressant and analgesic. Synthesized in 1904, it is not commonly used, but has activity similar to other opiates. Nicodicodeine is metabolised in the liver by demethylation to produce 6-nicotinoyldihydromorphine, and subsequently further metabolised to dihydromorphine. Since the final active metabolite is the slightly stronger opiate dihydromorphine rather than morphine, nicodicodeine can be expected to be marginally more potent and longer acting than nicocodeine. Side effects are similar to those of other opiates and include itching, nausea and respiratory depression.

This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it.v · d · e